Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors
Portfolio Pulse from
Altimmune has appointed Teri Lawver and Jerry Durso to its Board of Directors. Lawver brings experience from Dexcom and Johnson & Johnson, enhancing Altimmune's leadership with her extensive background in commercial operations and portfolio management.
February 25, 2025 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Altimmune has appointed Teri Lawver and Jerry Durso to its Board of Directors. Lawver's experience from Dexcom and Johnson & Johnson is expected to enhance Altimmune's strategic direction and commercial operations.
The appointment of experienced executives like Teri Lawver, with a strong background in commercial operations and portfolio management, is likely to positively influence Altimmune's strategic direction and operational efficiency. This could lead to improved investor confidence and a potential short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100